These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 2510837)

  • 21. Necrotizing vasculitis at granulocyte-macrophage-colony-stimulating factor injection sites.
    Farmer KL; Kurzrock R; Gutterman JU; Duvic M
    Arch Dermatol; 1990 Sep; 126(9):1243-4. PubMed ID: 2204310
    [No Abstract]   [Full Text] [Related]  

  • 22. [Expectations in the clinical application of human-recombinant cytokines. 4) Interleukin-3 and colony-stimulation factors].
    Takaku F
    Nihon Rinsho; 1988 May; 46(5):1105-11. PubMed ID: 2457722
    [No Abstract]   [Full Text] [Related]  

  • 23. Reactivation of rheumatoid arthritis and development of leukocytoclastic vasculitis in a patient receiving granulocyte colony-stimulating factor for Felty's syndrome.
    Vidarsson B; Geirsson AJ; Onundarson PT
    Am J Med; 1995 Jun; 98(6):589-91. PubMed ID: 7539978
    [No Abstract]   [Full Text] [Related]  

  • 24. The promise of colony-stimulating factors in clinical practice.
    Glaspy JA; Ambersley JM
    Oncol Nurs Forum; 1990; 17(1 Suppl):20-4. PubMed ID: 1689043
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of granulocyte-macrophage colony-stimulating factor on neutropenia and related morbidity induced by myelotoxic chemotherapy.
    Herrmann F; Schulz G; Wieser M; Kolbe K; Nicolay U; Noack M; Lindemann A; Mertelsmann R
    Haematol Blood Transfus; 1990; 33():717-23. PubMed ID: 2182461
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [GM-CSF: its use in onco-hematologic diseases].
    Visani G; Tosi P; Benfenati D; Colombini R; Cenacchi AR; Gamberi B; Lemoli RM; Tura S
    Haematologica; 1989 Oct; 74(5 Suppl):501-10. PubMed ID: 2512232
    [No Abstract]   [Full Text] [Related]  

  • 27. Use of recombinant human granulocyte macrophage colony-stimulating factor to speed engraftment and treat graft failure following marrow transplantation in man.
    Appelbaum FR; Nemunaitis J; Singer JW; Buckner CD; Storb R; Thomas ED
    Haematol Blood Transfus; 1990; 33():736-40. PubMed ID: 2182464
    [No Abstract]   [Full Text] [Related]  

  • 28. Clinical role of granulocyte-macrophage colony-stimulating factor.
    Mitsuyasu RT; Golde DW
    Hematol Oncol Clin North Am; 1989 Sep; 3(3):411-25. PubMed ID: 2698875
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Use of recombinant human granulocyte-macrophage colony-stimulating factor in autologous marrow transplantation for lymphoid malignancies.
    Nemunaitis J; Singer JW; Buckner CD; Hill R; Storb R; Thomas ED; Appelbaum FR
    Blood; 1988 Aug; 72(2):834-6. PubMed ID: 3042050
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Congenital neutropenia: a case study.
    Daghistani D; Jimenez JJ; Toledano SR; Cirocco RE; Yunis AA
    Am J Pediatr Hematol Oncol; 1990; 12(2):210-4. PubMed ID: 1696074
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Methimazole-induced agranulocytosis and granulocyte-colony stimulating factor.
    Heinrich B; Gross M; Goebel FD
    Ann Intern Med; 1989 Oct; 111(7):621-2. PubMed ID: 2672934
    [No Abstract]   [Full Text] [Related]  

  • 32. Hematopoietic growth factors: biology and clinical application.
    Gabrilove JL; Jakubowski A
    J Natl Cancer Inst Monogr; 1990; (10):73-7. PubMed ID: 1693284
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Recombinant human granulocyte-macrophage colony-stimulating factor in patients with myelodysplastic syndromes--a phase-I/II trial.
    Ganser A; Völkers B; Greher J; Walther F; Hoelzer D
    Onkologie; 1988 Feb; 11(1):53-5. PubMed ID: 3283627
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical applications of colony-stimulating factors.
    Groopman JE
    Semin Oncol; 1988 Dec; 15(6 Suppl 6):27-33. PubMed ID: 2462748
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Recombinant human granulocyte-macrophage colony-stimulating factor in AIDS.
    N Engl J Med; 1988 Mar; 318(9):579-80. PubMed ID: 3277058
    [No Abstract]   [Full Text] [Related]  

  • 36. G-CSF in Felty's syndrome: correction of neutropenia and effects on cytokine release.
    Schots R; Verbruggen LA; Demanet C
    Clin Rheumatol; 1995 Jan; 14(1):116-8. PubMed ID: 7538060
    [No Abstract]   [Full Text] [Related]  

  • 37. Stimulation of myelopoiesis in chronic lymphocytic leukemia and in other lymphoproliferative disorders by recombinant human granulocyte-macrophage colony-stimulating factor.
    Vadhan-Raj S; Velasquez WS; Butler JJ; LeMaistre A; Lepe-Zuniga J; Keating MJ; Koller CA; Gutterman JU
    Am J Hematol; 1990 Mar; 33(3):189-97. PubMed ID: 2405649
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [GM-CSF: its clinical administration; the treatment of aplasia].
    Rossi Ferrini P; Grossi A; Santini V; Vannucchi AM
    Haematologica; 1989 Oct; 74(5 Suppl):489-500. PubMed ID: 2512231
    [No Abstract]   [Full Text] [Related]  

  • 39. Recurrent spleen enlargement during cyclic granulocyte-macrophage colony-stimulating factor therapy for myelodysplastic syndrome.
    Delmer A; Karmochkine M; Cadiou M; Gerhartz H; Zittoun R
    Am J Hematol; 1990 May; 34(1):73-4. PubMed ID: 2183595
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment of neutropenia associated with dyskeratosis congenita with granulocyte-macrophage colony-stimulating factor.
    Russo CL; Glader BE; Israel RJ; Galasso F
    Lancet; 1990 Sep; 336(8717):751-2. PubMed ID: 1975922
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.